Durvalumab plus tremelimumab for the treatment of patients (pts) with refractory and progressive advanced thyroid carcinoma: A phase II multicohort trial (DUTHY / GETNE T1812)

Durvalumab plus tremelimumab for the treatment of patients (pts) with refractory and progressive advanced thyroid carcinoma: A phase II multicohort trial (DUTHY / GETNE T1812)

Saved in:
Bibliographic Details
Published in:Annals of oncology Vol. 30; p. v759
Main Authors: Hernando Cubero, J., Taberna Sanz, M., Carmona Bayonas, A., Iglesias, L., Grande, E., Trigo Perez, J.M., Grau, J.J., Lopez-Picazo, J.M., Castelo, B., Alonso Gordoa, T., Lorenzo, I., Casado Herraez, A., Ugidos, L., Munarriz, J., Lavernia, J., Capdevila, J.
Format: Journal Article
Language:English
Published: 01-10-2019
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0923-7534
DOI:10.1093/annonc/mdz267.009